Posted by New Delhi: Mankind Pharma, an Indian pharmaceutical manufacturer has collaborated with Accenture to drive its digital transformation. This has helped Mankind Pharma to become an intelligent enterprise, improving business agility, performance and operational efficiency.
Accenture said that it has redesigned the pharma major’s business processes across key functions. That includes finance, supply chain, sales and procurement for better inventory optimisation, demand planning, workforce productivity and product availability.
As part of the digital transformation project, Accenture deployed a digital platform based on SAP S/4HANA, a Microsoft Azure cloud-based data lake and Tableau dashboards. The solutions along with cloud-based analytics help Mankind Pharma get deeper insights into its global business operations and performance.
The platform integrates data in real-time from multiple sources across the supply chain, workforce and sales. It will provide a consolidated view of market insights. This can help the management team make informed decisions around business strategy, planning and product development.
The project was completed remotely during the ongoing pandemic with no impact on business continuity.
“At Mankind Pharma, we are committed to product innovation so we can provide high quality and affordable pharmaceutical products to people across the world,” said Arjun Juneja, COO – Mankind Pharma.
“Digitally transforming our business processes with support from Accenture has been key to unlocking value trapped within the organisation, accelerating real time decision making and improving our product innovation lifecycle,” added Juneja.
“Digital reinvention can not only help pharma companies deliver high-quality and hyper-personalized services. But also improve business performance and build resilience against future disruptions,” said Rishabh Bindlish, India Life Sciences and Global Generics Lead, Accenture.
“We are focused on helping Mankind Pharma embrace change and emerge as a data-driven enterprise to enhance its customer-centricity bringing innovative offerings to market at a faster pace and scale for patients,” added Bindlish.
(Image credit – Business Standard)